Pathogenesis of hepatocellular carcinoma: A review from the viewpoint of molecular analysis

Seminars in Surgical Oncology

Volumn 12, Issue 3, 1996, Pages 155-159

  Kasai, Yasushi ^a   Takeda, Shin ^a   Takagi, Hiroshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

hepatitis B virus (HBV); hepatitis C virus (HCV); hepatocellular carcinoma (HCC); integration of HBV; loss of heterozygosity (LOH); p53

Indexed keywords

VIRUS DNA;

CANCER RISK; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER REGENERATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION;

CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; GENES, P53; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 0029884168     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199605/06)12:3<155::AID-SSU2>3.0.CO;2-6     Document Type: Review

References (40)

1. Rosa GS, Calogero C, Felice F, et al.: Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 36:962-972, 1991.
2. Tanaka K, Hirohata T, Koga S, et al.: Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 51:2842-2847, 1991.
3. Nalpas B, Driss F, Pol S, et al.: Association between HCV and HBV infection in hepatocellular carcinoma. J Hepatol 12:70-74, 1991.
4. Okuda K: Primary liver cancer (Quadrennial review lecture). Dig Dis Sci 31:133s-146s, 1986.
5. Shafritz DA, Kew MC: Indentification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinoma. Hepatology 1:1-8, 1981.
6. Brechot C, Pourcel C, Louise A, et al.: Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286:533-535, 1980.
7. Chakraborty P, Ruiz ON, Shouval D, Shafritz DA: Identification of integrated hepatitis B virus DNA and expression of viral DNA in an HBsAg producing hepatocellular carcinoma cell line. Nature 286:531-532, 1980.
8. Takada S, Gotoh Y, Hayashi S, et al.: Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues. J Virol 64:822-828, 1990.
9. Fourel G, Trepo C, Bougueleret L, et al.: Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 347:294-298, 1990.
10. Wang J, Chenivesse X, Henglein B, Brechot C: Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343:555-557, 1990.
11. de The H, Marchio A, Tiollais P, Dejean A: A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature 330:667-670, 1987.
12. Tiollais P, Pourcel C, Dejean A: The hepatitis B virus. Nature 317:489-495, 1985.
13. Seto E, Yen TSB, Peterlin BM, Ou JH: Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci USA 85:8286-8290, 1988.
14. Takada S, Koike K: Trans-activation function of a 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 87:5628-5632, 1990.
15. Shirakata Y, Kawada M, Fujiki Y, et al.: The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res 80:617-621, 1989.
16. Kim CM, Koike K, Saito I, et al.: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-320, 1991.
17. Wang W, London WT, Feitelson MA: Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 51:4971-4977, 1991.
18. Diamantis ID, McGandy CE, Chen TJ, et al.: Hepatitis B X-gene expression in hepatocellular carcinoma. J Hepatol 15:400-403, 1992.
19. Choo QL, Kuo G, Weiner AJ, et al.: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362, 1989.
20. Choo QL, Weiner AJ, Overby LR, et al.: Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. Br Med Bull 46:423-441, 1990.
21. Kuo G, Choo QL, Alter HJ, et al.: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364, 1989.
22. Chiba J, Ohba H, Matsuura Y, et al.: Serodiagnosis of hepatitis C virus (HCV) infection with a HCV core protein molecularly expressed by a recombinant baculovirus. Proc Natl Acad Sci USA 88:4641-4645, 1991.
23. Van der Poel CL, Cuypers HT, Reesink HW, et al.: Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 337:317-319, 1991.
24. Nishioka K, Watanabe J, Furuta S, et al.: A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 67:429-433, 1991.
25. Paterlini P, Driss F, Nalpas B, et al.: Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-Negative patients: a study of a low-endemic area. Hepatology 17:20-28, 1993.
26. Shibata M, Takeda S, Kudo T, et al.: Minus strand RNA of hepatitis C virus in liver tissues [letter]. J Hepatol 13:379-380, 1991.
27. Takeda S, Shibata M, Morishiima T, et al.: Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus-strand and minus-strand viral RNA. Cancer 70:2255-2259, 1992.
28. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453-456, 1991.
29. Hsu IC, Metcalf RA, Sun T, et al.: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428, 1991.
30. Bressac B, Kew M, Wands J, Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-430, 1991.
31. Scorsone KA, Zhou YZ, Butel JS, Slagle BL: p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 52:1635-1638, 1992.
32. Oda T, Tsuda H, Scarpa A, et al.: p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 52:6358-6364, 1992.
33. Tsuda H, Hirohashi S, Shimosato Y, et al.: Low incidence of point of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res 80:196-199, 1989.
34. Takada S, Koike K: Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells. Oncogene 4:189-193, 1989.
35. Wang HP, Rogler CE: Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinoma. Cytogenet Cell Genet 48:72-78, 1988.
36. Buetow KH, Murray JC, Israel JL, et al.: Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86:8852-8856, 1989.
37. Tsuda H, Zhang W, Shimosato Y, et al.: Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6791-6794, 1990.
38. Zhang W, Hirohashi S, Tsuda H, et al.: Frequent loss of heterozygosity of chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 81:108-111, 1990.
39. Fujimori M, Tokino T, Hino O, et al.: Allelotype study of primary hepatocellular carcinoma. Cancer Res 51:89-93, 1991.
40. Simon D, Knowles BB, Weith A: Abnormalities of chromosome 1 and loss of heterozygosity of 1p in primary hepatomas. Oncogene 6:765-770, 1991.